Ronald Andrews
2020
In 2020, Ronald Andrews earned a total compensation of $1M as President and Chief Executive Officer at Oncocyte Corp, a 49% decrease compared to previous year.
Compensation breakdown
| Bonus | $465,600 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $9,190 |
| Option Awards | $68,500 |
| Salary | $487,385 |
| Other | $16,175 |
| Total | $1,046,850 |
Andrews received $487.4K in salary, accounting for 47% of the total pay in 2020.
Andrews also received $465.6K in bonus, $9.2K of change in pension value and nonqualified deferred compensation earnings, $68.5K in option awards and $16.2K in other compensation.
Rankings
In 2020, Ronald Andrews' compensation ranked 8,428th out of 13,090 executives tracked by ExecPay. In other words, Andrews earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,428 out of 13,090 | 36th |
Division Manufacturing | 3,582 out of 5,624 | 36th |
Major group Chemicals And Allied Products | 1,451 out of 2,257 | 36th |
Industry group Drugs | 1,263 out of 1,957 | 36th |
Industry In Vitro and In Vivo Diagnostic Substances | 30 out of 60 | 50th |
Source: SEC filing on May 21, 2021.
Andrews' colleagues
We found three more compensation records of executives who worked with Ronald Andrews at Oncocyte Corp in 2020.